| 1 (185) | Hoffmann-La Roche, GmbH., Germany | DEU |  |
| 2 (228) | Novartis Institutes for Biomedical Research, Switzerland | CHE | |
| 3 (292) | AstraZeneca, United Kingdom | GBR | |
| 4 (311) | Hoffmann-La Roche Ltd, Switzerland | CHE | |
| 5 (313) | Philips Research, Eindhoven | NLD | |
| 6 (359) | Siemens AG, Germany | DEU | |
| 7 (372) | Novo Nordisk A/S | DNK | |
| 8 (379) | Danone Nederland BV | NLD | |
| 9 (414) | VTT Technical Research Centre of Finland | FIN | |
| 10 (424) | Merck KGaA, Germany | DEU | |
| 11 (447) | Sanofi, France | FRA | |
| 12 (486) | Janssen Research & Development, LLC | BEL | |
| 13 (488) | Bayer AG, Germany | DEU | |
| 14 (554) | AstraZeneca, Sweden | SWE | |
| 15 (590) | Boehringer Ingelheim GmbH Germany | DEU | |
| 16 (600) | Siemens Healthineers, Germany | DEU | |
| 17 (622) | Novartis, Switzerland | CHE | |
| 18 (636) | Nestle Switzerland | CHE | |
| 19 (717) | Sanofi Pasteur MSD, France | FRA | |
| 20 (728) | GlaxoSmithKline, United Kingdom | GBR | |
| 21 (741) | Bosch, Germany | DEU | |
| 22 (933) | UCB Pharma SA, Belgium | BEL | |
| 23 (982) | IMEC International | BEL | |
| 24 (1116) | Hypertension Arterielle, Pulmonaire: Physiopathologie et Innovation Therapeutique | FRA | |
| 25 (1123) | BASF, Germany | DEU | |
| 26 (1292) | GlaxoSmithKline, Belgium | BEL | |
| 27 (1883) | SINTEF Group | NOR | |
| 28 (2144) | Sanofi, Germany | DEU | |
| 29 (2146) | Pfizer Inc, United Kingdom | GBR | |
|
